Benzocaine/tetracaine - Cetylite Industries

Drug Profile

Benzocaine/tetracaine - Cetylite Industries

Alternative Names: Benzocaine/tetracaine; CTY-5339; CTY-5339 Anesthetic Spray; CTY-5339-A; Tetracaine/benzocaine

Latest Information Update: 02 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cetylite
  • Class Anaesthetics; Local anaesthetics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Anaesthesia

Most Recent Events

  • 01 Jul 2017 Cetylite initiates enrolment in a phase II trial for Anesthesia (In volunteers) in USA (NCT03233737)
  • 07 Jun 2017 Cetylite completes a phase II trial in Anesthesia (In volunteers) in USA (NCT02908620)
  • 03 Oct 2016 Preclinical trials in Anaesthesia in USA (Topical) (NCT02908620) before October 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top